In a retrospective analysis involving a cohort of 160 patients with triple-positive aPL tests, the cumulative occurrence of thrombosis escalated to 12.2%, 26.1%, and 44.2% following 1, 5, and 10 years of monitoring, respectively. This evidence concerns the gene FASLG and Venous thrombosis.